• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2007-2011 年澳大利亚 20-64 岁成年人中,循环流行株与疫苗株匹配程度不同导致流感疫苗效力存在差异。

Moderate influenza vaccine effectiveness with variable effectiveness by match between circulating and vaccine strains in Australian adults aged 20-64 years, 2007-2011.

机构信息

Victorian Infectious Diseases Reference Laboratory, Melbourne, Vic., Australia.

出版信息

Influenza Other Respir Viruses. 2013 Sep;7(5):729-37. doi: 10.1111/irv.12018. Epub 2012 Oct 19.

DOI:10.1111/irv.12018
PMID:23078073
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5781205/
Abstract

BACKGROUND

Influenza vaccines are licensed annually based on immunogenicity studies. We used five sequential years of data to estimate influenza vaccine effectiveness (VE), the critical outcome in the field.

METHODS

Between 2007 and 2011, we performed annual prospective test-negative design case-control studies among adults aged 20-64 years recruited from sentinel general practices in the Australian state of Victoria. We used PCR-confirmed influenza as the endpoint to estimate influenza VE for all years. We compared annual VE estimates with the match between circulating and vaccine strains, determined by haemagglutination inhibition assays.

RESULTS

The adjusted VE estimate for all years (excluding 2009) was 62% (95% CI 43, 75). By type and subtype, the point estimates of VE by year ranged between 31% for seasonal influenza A(H1N1) and 88% for influenza A(H1N1)pdm09. In 2007, when circulating strains were assessed as incompletely matched, the point estimate of the adjusted VE against all influenza was 58%. The point estimate was 59% in 2011 when all strains were assessed as well matched.

CONCLUSION

Trivalent inactivated vaccines provided moderate protection against laboratory-confirmed influenza in adults of working age, although VE estimates were sensitive to the model used. VE estimates correlated poorly with circulating strain match, as assessed by haemagglutination inhibition assays, suggesting a need for VE studies that incorporate antigenic characterization data.

摘要

背景

流感疫苗是基于免疫原性研究每年获得许可的。我们使用连续五年的数据来估计流感疫苗的有效性(VE),这是该领域的关键结果。

方法

在 2007 年至 2011 年期间,我们在澳大利亚维多利亚州的哨点普通实践中,对 20-64 岁的成年人进行了年度前瞻性测试阴性设计病例对照研究。我们使用 PCR 确诊的流感作为终点来估计所有年份的流感 VE。我们将每年的 VE 估计值与通过血凝抑制测定确定的循环和疫苗株之间的匹配进行了比较。

结果

所有年份(不包括 2009 年)的调整 VE 估计值为 62%(95%CI 43,75)。按类型和亚型,每年 VE 的点估计值范围在季节性流感 A(H1N1)的 31%至 A(H1N1)pdm09 的 88%之间。在 2007 年,当评估循环株时,调整后的 VE 点估计值为 58%。在所有株均被评估为完全匹配的 2011 年,点估计值为 59%。

结论

三价灭活疫苗为工作年龄成年人提供了针对实验室确诊流感的中度保护,尽管 VE 估计值对所使用的模型敏感。VE 估计值与通过血凝抑制测定评估的循环株匹配相关性较差,表明需要进行 VE 研究,纳入抗原特征数据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7551/5781205/e9118049debe/IRV-7-729-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7551/5781205/e9118049debe/IRV-7-729-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7551/5781205/e9118049debe/IRV-7-729-g001.jpg

相似文献

1
Moderate influenza vaccine effectiveness with variable effectiveness by match between circulating and vaccine strains in Australian adults aged 20-64 years, 2007-2011.2007-2011 年澳大利亚 20-64 岁成年人中,循环流行株与疫苗株匹配程度不同导致流感疫苗效力存在差异。
Influenza Other Respir Viruses. 2013 Sep;7(5):729-37. doi: 10.1111/irv.12018. Epub 2012 Oct 19.
2
Component-specific effectiveness of trivalent influenza vaccine as monitored through a sentinel surveillance network in Canada, 2006-2007.2006 - 2007年通过加拿大一个哨点监测网络监测的三价流感疫苗的特定组分有效性
J Infect Dis. 2009 Jan 15;199(2):168-79. doi: 10.1086/595862.
3
Beyond Antigenic Match: Possible Agent-Host and Immuno-epidemiological Influences on Influenza Vaccine Effectiveness During the 2015-2016 Season in Canada.超越抗原匹配:2015-2016 年加拿大流感季节疫苗效力的可能宿主和免疫流行病学影响因素。
J Infect Dis. 2017 Dec 19;216(12):1487-1500. doi: 10.1093/infdis/jix526.
4
Effectiveness of trivalent seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2012/13 end of season results.三价季节性流感疫苗在英国初级保健中预防实验室确诊流感的效果:2012/13 季末结果。
Euro Surveill. 2014 Jul 10;19(27):5-13.
5
Integrated Sentinel Surveillance Linking Genetic, Antigenic, and Epidemiologic Monitoring of Influenza Vaccine-Virus Relatedness and Effectiveness During the 2013-2014 Influenza Season.2013 - 2014流感季节期间,整合哨点监测以关联流感疫苗病毒相关性和有效性的基因、抗原及流行病学监测
J Infect Dis. 2015 Sep 1;212(5):726-39. doi: 10.1093/infdis/jiv177. Epub 2015 Mar 17.
6
Estimation of type- and subtype-specific influenza vaccine effectiveness in Victoria, Australia using a test negative case control method, 2007-2008.使用病例对照试验阴性研究方法估计澳大利亚维多利亚州 2007-2008 年各型别及亚型流感疫苗的效果。
BMC Infect Dis. 2011 Jun 14;11:170. doi: 10.1186/1471-2334-11-170.
7
Effectiveness of inactivated influenza vaccines varied substantially with antigenic match from the 2004-2005 season to the 2006-2007 season.从2004 - 2005年流感季节到2006 - 2007年流感季节,灭活流感疫苗的有效性因抗原匹配程度不同而有很大差异。
J Infect Dis. 2009 Jan 15;199(2):159-67. doi: 10.1086/595861.
8
Interim within-season estimate of the effectiveness of trivalent inactivated influenza vaccine--Marshfield, Wisconsin, 2007-08 influenza season.三价灭活流感疫苗有效性的季节内中期估计——威斯康星州马什菲尔德,2007 - 2008年流感季节
MMWR Morb Mortal Wkly Rep. 2008 Apr 18;57(15):393-8.
9
Vaccine effectiveness in preventing laboratory-confirmed influenza in primary care patients in a season of co-circulation of influenza A(H1N1)pdm09, B and drifted A(H3N2), I-MOVE Multicentre Case-Control Study, Europe 2014/15.2014/15 年在欧洲,I-MOVE 多中心病例对照研究中,在甲型 H1N1pdm09、乙型和漂移型甲型 H3N2 流感共同流行的季节,初级保健患者中预防实验室确诊流感的疫苗效力。
Euro Surveill. 2016;21(7):pii=30139. doi: 10.2807/1560-7917.ES.2016.21.7.30139.
10
Low interim influenza vaccine effectiveness, Australia, 1 May to 24 September 2017.2017年5月1日至9月24日,澳大利亚流感疫苗中期有效性较低。
Euro Surveill. 2017 Oct;22(43). doi: 10.2807/1560-7917.ES.2017.22.43.17-00707.

引用本文的文献

1
Estimated health and economic impact of using high-dose influenza vaccine on respiratory and circulatory plus respiratory hospitalizations of older adults in Australia.澳大利亚使用高剂量流感疫苗对老年人呼吸道及循环系统加呼吸道住院情况的健康和经济影响估计
Vaccine X. 2023 Aug 4;15:100365. doi: 10.1016/j.jvacx.2023.100365. eCollection 2023 Dec.
2
Comparison of the Hemagglutination Inhibition Titers against Influenza Vaccine Strains in Japan from the 2017/2018 to 2021/2022 Seasons Using a Single Set of Serum Samples.比较 2017/2018 至 2021/2022 季节日本使用单一组血清样本的流感疫苗株血凝抑制滴度。
Viruses. 2022 Jun 30;14(7):1455. doi: 10.3390/v14071455.
3

本文引用的文献

1
A sentinel platform to evaluate influenza vaccine effectiveness and new variant circulation, Canada 2010-2011 season.2010-2011 年加拿大流感季节中用于评估流感疫苗效力和新变异株传播的哨点平台。
Clin Infect Dis. 2012 Aug;55(3):332-42. doi: 10.1093/cid/cis431. Epub 2012 Apr 26.
2
Effectiveness of the 2010-11 seasonal trivalent influenza vaccine in Spain: cycEVA study.西班牙 2010-11 年季节性三价流感疫苗的有效性:cycEVA 研究。
Vaccine. 2012 May 21;30(24):3595-602. doi: 10.1016/j.vaccine.2012.03.048. Epub 2012 Mar 31.
3
Moderate influenza vaccine effectiveness in Victoria, Australia, 2011.
Evaluation of the Real-World Effectiveness of Vaccines against COVID-19 at a Local Level: Protocol for a Test-Negative Case-Control Study.
地方层面评估 COVID-19 疫苗的真实世界有效性:阴性对照病例对照研究方案
Vaccines (Basel). 2022 May 23;10(5):822. doi: 10.3390/vaccines10050822.
4
A Retrospective Test-Negative Case-Control Study to Evaluate Influenza Vaccine Effectiveness in Preventing Hospitalizations in Children.一项回顾性病例对照研究,评估流感疫苗在预防儿童住院方面的有效性。
Clin Infect Dis. 2021 Nov 16;73(10):1759-1767. doi: 10.1093/cid/ciab709.
5
Decline in Seasonal Influenza Vaccine Effectiveness With Vaccination Program Maturation: A Systematic Review and Meta-analysis.随着疫苗接种计划成熟,季节性流感疫苗效力下降:一项系统评价与荟萃分析
Open Forum Infect Dis. 2021 Feb 5;8(3):ofab069. doi: 10.1093/ofid/ofab069. eCollection 2021 Mar.
6
Using the health belief model to identify barriers to seasonal influenza vaccination among Australian adults in 2019.利用健康信念模型识别 2019 年澳大利亚成年人接种季节性流感疫苗的障碍。
Influenza Other Respir Viruses. 2021 Sep;15(5):678-687. doi: 10.1111/irv.12843. Epub 2021 Feb 15.
7
Pneumococcal colonization impairs mucosal immune responses to live attenuated influenza vaccine.肺炎球菌定植可损害黏膜免疫对减毒活流感疫苗的应答。
JCI Insight. 2021 Feb 22;6(4):141088. doi: 10.1172/jci.insight.141088.
8
The humoral immune response to high-dose influenza vaccine in persons with monoclonal B-cell lymphocytosis (MBL) and chronic lymphocytic leukemia (CLL).高剂量流感疫苗在单克隆 B 细胞淋巴瘤(MBL)和慢性淋巴细胞白血病(CLL)患者中的体液免疫反应。
Vaccine. 2021 Feb 12;39(7):1122-1130. doi: 10.1016/j.vaccine.2021.01.001. Epub 2021 Jan 16.
9
Variations in Seasonal Influenza Vaccine Effectiveness due to Study Characteristics: A Systematic Review and Meta-analysis of Test-Negative Design Studies.研究特征导致的季节性流感疫苗效力差异:一项针对检测阴性设计研究的系统评价和荟萃分析
Open Forum Infect Dis. 2020 May 21;7(7):ofaa177. doi: 10.1093/ofid/ofaa177. eCollection 2020 Jul.
10
Comparative epidemiology, phylogenetics, and transmission patterns of severe influenza A/H3N2 in Australia from 2003 to 2017.2003 至 2017 年澳大利亚严重季节性 A/H3N2 流感的比较流行病学、系统发生学和传播模式。
Influenza Other Respir Viruses. 2020 Nov;14(6):700-709. doi: 10.1111/irv.12772. Epub 2020 Jun 17.
澳大利亚维多利亚州 2011 年中度流感疫苗效力。
Euro Surveill. 2012 Mar 15;17(11):20115.
4
I-MOVE multi-centre case control study 2010-11: overall and stratified estimates of influenza vaccine effectiveness in Europe.I-MOVE 多中心病例对照研究 2010-11 年:欧洲流感疫苗效力的总体和分层估计。
PLoS One. 2011;6(11):e27622. doi: 10.1371/journal.pone.0027622. Epub 2011 Nov 15.
5
Vaccine effectiveness in preventing influenza hospitalizations in Navarre, Spain, 2010-2011: cohort and case-control study.西班牙纳瓦拉 2010-2011 年流感住院预防疫苗效力:队列和病例对照研究。
Vaccine. 2012 Jan 5;30(2):195-200. doi: 10.1016/j.vaccine.2011.11.024. Epub 2011 Nov 18.
6
Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis.流感疫苗的疗效和效果:系统评价和荟萃分析。
Lancet Infect Dis. 2012 Jan;12(1):36-44. doi: 10.1016/S1473-3099(11)70295-X. Epub 2011 Oct 25.
7
Effectiveness of H1N1/09 monovalent and trivalent influenza vaccines against hospitalization with laboratory-confirmed H1N1/09 influenza in Australia: a test-negative case control study.澳大利亚 H1N1/09 单价和三价流感疫苗对住院治疗实验室确诊 H1N1/09 流感的有效性:一项病例对照研究。
Vaccine. 2011 Oct 6;29(43):7320-5. doi: 10.1016/j.vaccine.2011.07.087. Epub 2011 Jul 31.
8
Influenza vaccine effectiveness in Wisconsin during the 2007-08 season: comparison of interim and final results.2007-08 年度威斯康星州流感疫苗效力:中期和最终结果比较。
Vaccine. 2011 Sep 2;29(38):6558-63. doi: 10.1016/j.vaccine.2011.07.002. Epub 2011 Jul 19.
9
Effectiveness of seasonal influenza vaccine against pandemic (H1N1) 2009 virus, Australia, 2010.季节性流感疫苗对 2010 年澳大利亚大流行性(H1N1)2009 病毒的有效性。
Emerg Infect Dis. 2011 Jul;17(7):1181-7. doi: 10.3201/eid1707.101959.
10
Estimation of type- and subtype-specific influenza vaccine effectiveness in Victoria, Australia using a test negative case control method, 2007-2008.使用病例对照试验阴性研究方法估计澳大利亚维多利亚州 2007-2008 年各型别及亚型流感疫苗的效果。
BMC Infect Dis. 2011 Jun 14;11:170. doi: 10.1186/1471-2334-11-170.